Clinical Trials
16 trialsNCT03374215 2026-06-05
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03206060 2026-04-24
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT03604198 2026-04-21
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting
NCT07470580 2026-03-13
ADERADHTA2
University Hospital, Toulouse
Phase NA Not yet recruiting
NCT01022515 2026-02-06
PHEO
University Hospital, Rouen
Phase NA Completed
NCT04530916 2025-11-17
WB2020
Colorado State University
Phase 1/2 Active not recruiting
NCT03697109 2025-07-16
GRACE
Corcept Therapeutics
Phase 3 Completed
NCT06090617 2024-03-19
WHYSKI
University Hospital Padova
Unknown
NCT04373265 2024-02-23
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Phase 1 Completed
NCT05839483 2023-07-17
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis
Zhongnan Hospital
Phase NA Unknown
NCT04566406 2020-09-28
Pheochromocytoma and Hemodynamic Instability
Jagiellonian University
Completed
NCT02804750 2019-10-15
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Phase 2 Completed
NCT02001051 2018-06-14
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT02772315 2017-01-26
ENSAT-HT
Radboud University Medical Center
Unknown
NCT01092078 2015-04-22
MISTER-B
NYU Langone Health
Phase NA Completed
NCT00001147 2008-03-04
Blood Sampling for Neurochemical and Genetic Testing
National Institutes of Health Clinical Center (CC)
Completed